Home
/
MEDICINOVA INC
/
Financials
/
Quarterly
MEDICINOVA INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MEDICINOVA INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2015
Mar 31, 2015
$0
May 11, 2015
Q1
2015
Mar 31, 2014
$0
May 11, 2015
Q3
2014
Sep 30, 2013
$3.3K
Nov 13, 2014
Q2
2014
Jun 30, 2013
$3.3K
Aug 13, 2014
Q1
2014
Mar 31, 2013
$3.3K
May 8, 2014
Q3
2013
Sep 30, 2012
$83.8K
Nov 7, 2013
Q2
2013
Jun 30, 2012
$493.6K
Aug 8, 2013
Q1
2013
Mar 31, 2012
$191.2K
May 8, 2013
Q3
2011
Sep 30, 2011
$0
Nov 14, 2011
Q2
2011
Jun 30, 2011
$0
Aug 15, 2011
Q3
2011
Sep 30, 2010
$0
Nov 14, 2011
Q2
2011
Jun 30, 2010
$0
Aug 15, 2011
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$123.3K
Nov 12, 2025
Q2
2025
Jun 30, 2025
$134.6K
Aug 14, 2025
Q3
2024
Sep 30, 2023
$1.00M
Nov 13, 2024
Q3
2022
Sep 30, 2021
$37.5K
Nov 10, 2022
Q2
2022
Jun 30, 2021
$4.00M
Aug 11, 2022
Q1
2022
Mar 31, 2021
$4.00M
May 12, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.05M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($3.28M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($3.28M)
Nov 12, 2025
Q3
2025
Mar 31, 2025
($2.86M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($2.86M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($2.86M)
May 13, 2025
Q3
2025
Sep 30, 2024
($2.85M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($2.63M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($2.63M)
Nov 12, 2025
Q1
2025
Mar 31, 2024
($2.75M)
May 13, 2025
Q2
2025
Mar 31, 2024
($2.75M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($2.75M)
Nov 12, 2025
Q3
2024
Sep 30, 2023
($723.1K)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($2.87M)
Aug 8, 2024
Q1
2023
Jun 30, 2023
($2.87M)
Aug 9, 2023
Q3
2024
Jun 30, 2023
($2.87M)
Nov 13, 2024
Q1
2024
Mar 31, 2023
($2.92M)
May 9, 2024
Q2
2024
Mar 31, 2023
($2.92M)
Aug 8, 2024
Q3
2024
Mar 31, 2023
($2.92M)
Nov 13, 2024
Q3
2023
Sep 30, 2022
($3.65M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.38M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($3.61M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.20M)
May 13, 2025
Q3
2025
Sep 30, 2024
($3.31M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($3.05M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($3.14M)
May 13, 2025
Q3
2024
Sep 30, 2023
($1.15M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.30M)
Aug 8, 2024
Q1
2023
Jun 30, 2023
($3.30M)
Aug 9, 2023
Q1
2024
Mar 31, 2023
($2.96M)
May 9, 2024
Q3
2023
Sep 30, 2022
($3.90M)
Nov 9, 2023
Q1
2023
Jun 30, 2022
($4.09M)
Aug 9, 2023
Q2
2022
Jun 30, 2022
($4.09M)
Aug 11, 2022
Q1
2023
Mar 31, 2022
($3.41M)
May 11, 2023
Q3
2022
Sep 30, 2021
($3.60M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($4.31M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($201.5K)
May 12, 2022
Q3
2021
Sep 30, 2020
($3.73M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($4.51M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($2.92M)
May 13, 2021